These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 12694953)

  • 1. Impact of a cost sharing drug insurance plan on drug utilization among individuals receiving social assistance.
    Blais L; Couture J; Rahme E; LeLorier J
    Health Policy; 2003 May; 64(2):163-72. PubMed ID: 12694953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of a cost-sharing drug insurance plan on drug utilization among older people.
    Blais L; Boucher JM; Couture J; Rahme E; LeLorier J
    J Am Geriatr Soc; 2001 Apr; 49(4):410-4. PubMed ID: 11347784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the adherence and persistence to inhaled corticosteroids among adult patients with public and private drug insurance plans.
    Cyr MC; Beauchense MF; Lemiere C; Blais L
    J Popul Ther Clin Pharmacol; 2013; 20(1):e26-41. PubMed ID: 23392860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of the type of insurance plan on adherence and persistence with antidepressants: a matched cohort study.
    Assayag J; Forget A; Kettani FZ; Beauchesne MF; Moisan J; Blais L
    Can J Psychiatry; 2013 Apr; 58(4):233-9. PubMed ID: 23547647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use and reimbursement costs of smoking cessation medication under the Quebec public drug insurance plan.
    Tremblay M; Payette Y; Montreuil A
    Can J Public Health; 2009; 100(6):417-20. PubMed ID: 20209733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of drug plans on adherence to and the cost of antihypertensive medications among patients covered by a universal drug insurance program.
    Després F; Perreault S; Lalonde L; Forget A; Kettani FZ; Blais L
    Can J Cardiol; 2014 May; 30(5):560-7. PubMed ID: 24613090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Difference in drug cost between private and public drug plans in Quebec, Canada.
    M C; A F; I C; M S; L B
    BMC Health Serv Res; 2022 Feb; 22(1):200. PubMed ID: 35164750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequent users of ambulatory health care in Quebec: the case of doctor-shoppers.
    Demers M
    CMAJ; 1995 Jul; 153(1):37-42. PubMed ID: 7796374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of two sequential drug cost-sharing policies on the use of inhaled medications in older patients with chronic obstructive pulmonary disease or asthma.
    Dormuth CR; Glynn RJ; Neumann P; Maclure M; Brookhart AM; Schneeweiss S
    Clin Ther; 2006 Jun; 28(6):964-78; discussion 962-3. PubMed ID: 16860179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Painful neuropathic disorders: an analysis of the Régie de l'Assurance Maladie du Québec database.
    Lachaine J; Gordon A; Choinière M; Collet JP; Dion D; Tarride JE
    Pain Res Manag; 2007; 12(1):31-7. PubMed ID: 17372632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Income-based drug benefit policy: impact on receipt of inhaled corticosteroid prescriptions by Manitoba children with asthma.
    Kozyrskyj AL; Mustard CA; Cheang MS; Simons FE
    CMAJ; 2001 Oct; 165(7):897-902. PubMed ID: 11599328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhaled corticosteroids and the risk of diabetes among the elderly.
    Dendukuri N; Blais L; LeLorier J
    Br J Clin Pharmacol; 2002 Jul; 54(1):59-64. PubMed ID: 12100226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adverse events associated with prescription drug cost-sharing among poor and elderly persons.
    Tamblyn R; Laprise R; Hanley JA; Abrahamowicz M; Scott S; Mayo N; Hurley J; Grad R; Latimer E; Perreault R; McLeod P; Huang A; Larochelle P; Mallet L
    JAMA; 2001 Jan 24-31; 285(4):421-9. PubMed ID: 11242426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhaled corticosteroids in COPD: determinants of use and trends in patient persistence with treatment.
    Blais L; Bourbeau J; Sheehy O; LeLorier J
    Can Respir J; 2004; 11(1):27-32. PubMed ID: 15010729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Socioeconomic status, drug insurance benefits, and new prescriptions for inhaled corticosteroids in schoolchildren with asthma.
    Kozyrskyj AL; Mustard CA; Simons FE
    Arch Pediatr Adolesc Med; 2001 Nov; 155(11):1219-24. PubMed ID: 11695930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accuracy of Self-reported Prescribed Analgesic Medication Use: Linkage Between the Quebec Pain Registry and the Quebec Administrative Prescription Claims Databases.
    Lacasse A; Ware MA; Bourgault P; Lanctôt H; Dorais M; Boulanger A; Cloutier C; Shir Y; Choinière M
    Clin J Pain; 2016 Feb; 32(2):95-102. PubMed ID: 25924096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Agreement between survey data and Régie de l'assurance maladie du Québec (RAMQ) data with respect to the diagnosis of asthma and medical services use for asthma in children.
    Plante C; Goudreau S; Jacques L; Tessier F
    Chronic Dis Inj Can; 2014 Nov; 34(4):256-62. PubMed ID: 25408185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of 3-tier formularies on drug treatment of attention-deficit/hyperactivity disorder in children.
    Huskamp HA; Deverka PA; Epstein AM; Epstein RS; McGuigan KA; Muriel AC; Frank RG
    Arch Gen Psychiatry; 2005 Apr; 62(4):435-41. PubMed ID: 15809411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Persistence and adherence to cholesterol lowering agents: evidence from Régie de l'Assurance Maladie du Québec data.
    Lachaine J; Rinfret S; Merikle EP; Tarride JE
    Am Heart J; 2006 Jul; 152(1):164-9. PubMed ID: 16824851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quebec employs user-pay philosophy in launching drug-insurance plan.
    Martin M
    CMAJ; 1996 Dec; 155(11):1604-5. PubMed ID: 8956840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.